Niagen Bioscience (NAGE) Capital Expenditures (2011 - 2020)

Niagen Bioscience (NAGE) has 8 years of Capital Expenditures data on file, last reported at $92000.0 in Q2 2020.

• On a quarterly basis, Capital Expenditures rose 33.33% year-over-year to $92000.0 in Q2 2020; TTM through Jun 2020 was $542000.0, a 52.68% increase from a year earlier, with the FY2019 full-year figure at $743000.0, down 43.75% from the prior year.
• Capital Expenditures for Q2 2020 stood at $92000.0, up from $15000.0 in the prior quarter.
• Over the last five years, Capital Expenditures for NAGE reached as high as $1.1 million in Q2 2018 and fell as low as $10000.0 in Q4 2018.
• Historically, Capital Expenditures has averaged $279722.4 across 5 years, with a median of $162000.0 in 2017.
• Across the five-year window, Capital Expenditures tumbled 96.61% in 2018 and soared 2700.0% in 2019, its largest moves.
• Year by year, Capital Expenditures stood at $563944.0 in 2016, then plunged by 47.69% to $295000.0 in 2017, then tumbled by 96.61% to $10000.0 in 2018, then surged by 2700.0% to $280000.0 in 2019, then tumbled by 67.14% to $92000.0 in 2020.
• Per Business Quant data, the three most recent Capital Expenditures figures were $92000.0 in Q2 2020, $15000.0 in Q1 2020, and $280000.0 in Q4 2019.